These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 8107674)

  • 1. Characterization of functionally important sites in the bacteriophage Mu transposase protein.
    Ulycznyj PI; Forghani F; DuBow MS
    Mol Gen Genet; 1994 Feb; 242(3):272-9. PubMed ID: 8107674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel DNA binding and nuclease activity in domain III of Mu transposase: evidence for a catalytic region involved in donor cleavage.
    Wu Z; Chaconas G
    EMBO J; 1995 Aug; 14(15):3835-43. PubMed ID: 7641701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A subsequence-specific DNA-binding domain resides in the 13 kDa amino terminus of the bacteriophage Mu transposase protein.
    Tolias PP; DuBow MS
    J Mol Recognit; 1989 Apr; 1(4):172-8. PubMed ID: 2561072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutational analysis of the att DNA-binding domain of phage Mu transposase.
    Kim K; Harshey RM
    Nucleic Acids Res; 1995 Oct; 23(19):3937-43. PubMed ID: 7479039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of residues in the Mu transposase essential for catalysis.
    Baker TA; Luo L
    Proc Natl Acad Sci U S A; 1994 Jul; 91(14):6654-8. PubMed ID: 7912831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions of the transposase with the ends of Mu: formation of specific nucleoprotein structures and non-cooperative binding of the transposase to its binding sites.
    Groenen MA; Vollering M; Krijgsman P; van Drunen K; van de Putte P
    Nucleic Acids Res; 1987 Nov; 15(21):8831-44. PubMed ID: 2825121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disassembly of the Mu transposase tetramer by the ClpX chaperone.
    Levchenko I; Luo L; Baker TA
    Genes Dev; 1995 Oct; 9(19):2399-408. PubMed ID: 7557391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancer-independent variants of phage Mu transposase: enhancer-specific stimulation of catalytic activity by a partner transposase.
    Yang JY; Jayaram M; Harshey RM
    Genes Dev; 1995 Oct; 9(20):2545-55. PubMed ID: 7590234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in domain III alpha of the Mu transposase: evidence suggesting an active site component which interacts with the Mu-host junction.
    Naigamwalla DZ; Coros CJ; Wu Z; Chaconas G
    J Mol Biol; 1998 Sep; 282(2):265-74. PubMed ID: 9735286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complete transposition requires four active monomers in the mu transposase tetramer.
    Baker TA; Kremenstova E; Luo L
    Genes Dev; 1994 Oct; 8(20):2416-28. PubMed ID: 7958906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A domain sharing model for active site assembly within the Mu A tetramer during transposition: the enhancer may specify domain contributions.
    Yang JY; Kim K; Jayaram M; Harshey RM
    EMBO J; 1995 May; 14(10):2374-84. PubMed ID: 7774595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The wing of the enhancer-binding domain of Mu phage transposase is flexible and is essential for efficient transposition.
    Clubb RT; Mizuuchi M; Huth JR; Omichinski JG; Savilahti H; Mizuuchi K; Clore GM; Gronenborn AM
    Proc Natl Acad Sci U S A; 1996 Feb; 93(3):1146-50. PubMed ID: 8577730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterisation of an IS1 induced mutation in the carboxy-terminal end of bacteriophage Mu transposase which affects several functional domains of the protein.
    Faelen M; Gama MJ; Toussaint A
    Biochimie; 1990 Sep; 72(9):697-701. PubMed ID: 2177657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein-DNA assemblies controlling lytic development of bacteriophage Mu.
    Baker TA
    Curr Opin Genet Dev; 1993 Oct; 3(5):708-12. PubMed ID: 8274852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cis-acting DNA sequences required in vivo for bacteriophage Mu helper-mediated transposition and packaging.
    Harel J; Duplessis L; Kahn JS; DuBow MS
    Arch Microbiol; 1990; 154(1):67-72. PubMed ID: 2168695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Step-arrest mutants of phage Mu transposase. Implications in DNA-protein assembly, Mu end cleavage, and strand transfer.
    Kim K; Namgoong SY; Jayaram M; Harshey RM
    J Biol Chem; 1995 Jan; 270(3):1472-9. PubMed ID: 7836417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ClpX and MuB interact with overlapping regions of Mu transposase: implications for control of the transposition pathway.
    Levchenko I; Yamauchi M; Baker TA
    Genes Dev; 1997 Jun; 11(12):1561-72. PubMed ID: 9203582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Instability of bacteriophage Mu transposase and the role of host Hfl protein.
    Gama MJ; Toussaint A; Pato ML
    Mol Microbiol; 1990 Nov; 4(11):1891-7. PubMed ID: 1964485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cloning of the A gene of bacteriophage Mu and purification of its product, the Mu transposase.
    Craigie R; Mizuuchi K
    J Biol Chem; 1985 Feb; 260(3):1832-5. PubMed ID: 2981873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MuA transposase separates DNA sequence recognition from catalysis.
    Goldhaber-Gordon I; Early MH; Baker TA
    Biochemistry; 2003 Dec; 42(49):14633-42. PubMed ID: 14661976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.